| Identification | Back Directory | [Name]
13,14-DIHYDRO-15-KETO PROSTAGLANDIN D2 | [CAS]
59894-07-4 | [Synonyms]
DK-PGD2
13,14-Dihydro-15-keto-PGD2
13,14-Dihydro-15-ketoprostadlandin D2
13,14-DIHYDRO-15-KETO PROSTAGLANDIN D2
9ALPHA-HYDROXY-11,15-DIOXO-PROST-5Z-EN-1-OIC ACID
13,14-dihydro-15-keto Prostaglandin D2
(5Z,9α)-9-Hydroxy-11,15-dioxoprost-5-en-1-oic acid
13,14-dihydro-15-keto Prostaglandin D2 MaxSpecStandard
13,14-dihydro-15-keto Prostaglandin D2 Lipid Maps MS Standard | [Molecular Formula]
C20H32O5 | [MDL Number]
MFCD00885499 | [MOL File]
59894-07-4.mol | [Molecular Weight]
352.47 |
| Hazard Information | Back Directory | [Description]
13,14-dihydro-15-keto Prostaglandin D2 (13,14-dihydro-15-keto PGD2) is a metabolite of PGD2 which is formed through the 15-hydroxy PGDH pathway. 13,14-dihydro-15-keto PGD2 was recently identified as a selective agonist for the CRTH2/DP2 receptor. It also inhibits ion flux in a canine colonic mucosa preparation. In humans, 13,14-dihydro-15-keto PGD2 is further metabolized to give 11β-hydroxy compounds which have also undergone β-oxidation of one or both side chains. Virtually no 13,14-dihydro-15-keto PGD2 survives intact in the urine. | [Uses]
13,14-Dihydro-15-keto-PGD2 is a metabolite of Prostaglandin D2 (CAT# P838575) and a selective CRTh2/DP2 receptor agonist. CRTh2/DP2 receptors play crucial roles in atopic dermatitis, asthma, and other inflammatory diseases. | [Definition]
ChEBI: 13,14-dihydro-15-ketoprostaglandin D2 is a prostaglandins D. It has a role as a metabolite. It is functionally related to a prostaglandin D2. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
| Company Name: |
amyjetsci
|
| Tel: |
027-59626688 18771149750 |
| Website: |
https://www.amyjet.com/ |
|